ITMCTR2023000064
Not yet recruiting
未知
A cohort study on the treatment of coronary heart disease with the method of promoting qi and blood circulation (prospective)
ConditionsCoronary heart disease
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Coronary heart disease
- Sponsor
- Xiyuan Hospital, China Academy of Chinese Medical Sciences
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •(1\) Meeting the diagnostic criteria for coronary heart disease in Western medicine; (2\) aged 18\-85 years; and (3\) signing an informed consent form.
Exclusion Criteria
- •(1\) Patients with severe primary diseases such as combined hepatic and renal insufficiency, hematopoietic system abnormalities, and neurological diseases; (2\) Pregnant or lactating women.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 2
A cohort study on the treatment of coronary heart disease with the method of promoting qi and blood circulation (retrospective)Coronary heart diseaseITMCTR2023000063Xiyuan Hospital, China Academy of Chinese Medical Sciences
Not yet recruiting
Not Applicable
Cohort Study on Treatment of Cardiovascular Diseases with Traditional Chinese MedicineCardiovascular DiseasesITMCTR2200005811Tianjin University of Traditional Chinese Medicine
Recruiting
Not Applicable
Clinical trial on the treatment of coronary microvascular disease with Shexiang Tongxin dropping pillcoronary microvascular diseaseITMCTR2024000027Guangdong provincial Hospital of Chinese Medicine
Completed
Phase 2
Treatment of cardiac amyloid light-chain amyloidosis with the green tea compound epigallocatechin-3-galiateAmyloid light-chain amyloidosisNutritional, Metabolic, EndocrineAmyloidosisISRCTN68399350Ruprecht-Karls-University of Heidelberg (Germany)38
Completed
Phase 3
P030 clinical trialJPRN-jRCT2080224719IPRO CORPORATIO312